Effect and Adverse events of polyethylene glycol preparation combination in constipated patients with severe motor and intellectual disability
Not Applicable
- Conditions
- severe motor and intellectual disability
- Registration Number
- JPRN-UMIN000048883
- Lead Sponsor
- ational Hospital Organization Higashisaga Hospital
- Brief Summary
By administration of MOVICOL, the number of spontaneous defecation was significantly increased (p = 0.04), and the number of usage of cure medicines (e.g. glycerin enema) was decreased (p = 0.03). Stool hardness did not differ before and after MOVICOL administration. No significant adverse events were observed. MOVICOL can be a new treatment option for patients with SMID who do not respond to conventional therapies for constipation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1)rectal intussuspocion, rectal prolapse, and megacolon inducing constipation 2)mechanical obstruction 3)past history of inflammatory bowel diseases, colorectal cancer, or bowel obstruction 4)physician determined ineligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method